Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Comparative effectiveness of anthracycline-containing chemotherapy in United States veterans age 80 and older with diffuse large B-cell lymphoma

Published:2015-05 Issue:3 Volume:6 Page:211-218
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Carson Kenneth R.,Riedell Peter,Lynch Ryan,Nabhan Chadi,Wildes Tanya M.,Liu Weijian,Ganti Arun,Roop Ryan,Sanfilippo Kristen M.,O'Brian Katiuscia,Liu Jingxia,Bartlett Nancy L.,Cashen Amanda,Wagner-Johnston Nina,Fehniger Todd A.,Colditz Graham A.

Funder

Barnes-Jewish Hospital Foundation

American Cancer Society

National Cancer Institute

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference42 articles.

1. Future of cancer incidence in the United States: burdens upon an aging, changing nation;Smith;J Clin Oncol,2009

2. Public Health and Aging: Trends in Aging — United States and Worldwide;Goulding;MMWR Morb Mortal Wkly Rep,2003

3. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma;Coiffier;N Engl J Med,2002

4. Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60);Pfreundschuh;Lancet Oncol,2008

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unmet Needs in the First-Line Treatment of Diffuse Large B-cell Lymphoma: Expert Recommendations From the Asia-Pacific Region With a Focus on the Challenging Subtypes;Clinical Lymphoma Myeloma and Leukemia;2024-09

2. Comparison of R‐CHOP‐14 and R‐mini‐CHOP in older adults with diffuse large B‐cell lymphoma—A retrospective multicenter cohort study;European Journal of Haematology;2024-07-31

3. Determination of the appropriate chemotherapy for patients aged 80 years or older with diffuse large B cell lymphoma;2024-06-12

4. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study;The Korean Journal of Internal Medicine;2024-05-01

5. Decreasing polypharmacy in older adults with cancer: A pilot cluster-randomized trial protocol;Journal of Geriatric Oncology;2024-03